Nebivolol Tablet
Product Images NDC 59651-138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nebivolol (NDC 59651-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))
This is a medication package for Nebivolol Tablets made by Aurobindo Pharma USA. Each package contains 30 tablets, with each tablet having Nebivolol hydrochloride equivalent to 25 mg nebivolol. It is for prescription use only and should be kept out of reach of children. The tablets should be stored in a tight light-resistant container at 20° to 25°C. Dosage and prescription information can be found in the package insert. The medication is distributed by Aurobindo Pharma USA and made in India.*
FDA Label Image

Package Label-principal Display Panel – 5 mg (30 Tablets Bottle) (Nebivolol Fig2)

Package Label-principal Display Panel – 5 mg (30 Tablets Bottle) (Nebivolol Fig2)
This is a prescription drug labeled as Nebivolol Tablets, manufactured by Aurobindo Pharma USA. It comes in a package of 30 tablets containing 5 mg of Nebivolol hydrachiride each. It is advised to keep the drug out of children's reach and store it in a light-resistant container at 20° to 25°C. The package insert must be referred to for dosage and prescribing information. The drug contains FD&C Yellow No5 as a color additive. The label also provides information on the distributor and the manufacturing country. There is a printing zone coding area, specifically marked, which should not be printed.*
FDA Label Image

Package Label-principal Display Panel – 10 mg (30 Tablets Bottle) (Nebivolol Fig3)

Package Label-principal Display Panel – 10 mg (30 Tablets Bottle) (Nebivolol Fig3)
This is a description of a medication called Nebivolol tablets. The tablets are distributed by Aurbindo Pharma USA and have a specific code, AP/DRUGS/04/2016. The recommended storage temperature is between 20 and 25 degrees Celsius. The medication is used to treat chlorsistant closure and the recommended dosage is mentioned in the package insert. The text also has information on where the medication is distributed and a warning to keep it away from the reach of children. There is a coding area in the packaging that should not be printed on.*
FDA Label Image

Package Label-principal Display Panel – 20 mg (30 Tablets Bottle) (Nebivolol Fig4)

Package Label-principal Display Panel – 20 mg (30 Tablets Bottle) (Nebivolol Fig4)
Nebivolol Tablets are a prescription medication that come in a bottle of 30 tablets, each containing 20 mg of nebivolol hydrochloride, manufactured by Aurobindo Pharma USA, Inc. It is important to store the tablets in a tight, light-resistant container out of reach of children at a temperature of 20 to 25°C (68° to 77°F). The usual recommended dosage can be found in the package insert for dosing and prescription information.*
FDA Label Image

Chemical Structure (Nebivolol Str)

Chemical Structure (Nebivolol Str)
This is a chemical compound description for two versions of nebivolol hydrochloride, labeled as SRRR and RSSS. The molecular weight of both versions is 441.90 grams per mole and they are combined with hydrochloride.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.